Iconic Therapeutics, Inc.

iconictherapeutics.com

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines. Our deep understanding of the role of Tissue Factor in angiogenesis, inflammation and malignancies has led us to a new approach to developing therapies for devastating diseases such as macular degeneration and cancer.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

DELFI DIAGNOSTICS SELECTED AS THE LIQUID BIOPSY PARTNER FOR 4-IN-THE-LUNG-RUN: A LARGE-SCALE EUROPEAN LUNG CANCER SCREENING STUDY

Delfi Diagnostics | September 12, 2022

news image

Delfi Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has been selected as the liquid lung cancer biopsy partner in Europe's multi-national, randomized, prospective lung cancer screening trial known as 4-IN-THE-LUNG-RUN, or 4ITLR. Through 4ITLR, European investigators are studying how often – every year, or every other year – individuals should get screened if their in...

Read More

Industrial Impact

AMNIO TECHNOLOGY LAUNCHES TWO NEW DUAL-LAYER ALLOGRAFTS, FDA RECOGNIZES PRODUCTS AS MINIMALLY MANIPULATED, HOMOLOGOUS USE HCT/PS

Amnio Technology | February 15, 2022

news image

Amnio Technology, a global leader in the development of and distribution of amniotic tissue allografts is announcing the launch of two new PalinGen® membrane products, PalinGen® Dual-Layer Membrane and Dual Layer PalinGen® X-Membrane. The new allografts, like the entire family of PalinGen® membrane products, are minimally manipulated, homologous use and chorion-free. The dual-layered nature of the allografts allow for unidirectional application with two outward facing epithelial ...

Read More

MedTech, Industrial Impact

SYNERGY ONCOLOGY TO USE SOPHIA DDM FOR NEW CANCER PROFILING SOLUTION

SOPHiA GENETICS | March 01, 2023

news image

On February 28, 2023, SOPHiA GENETICS, a leading cloud-native software solutions provider in the healthcare space, announced that Synergy Oncology, a part of Synergy Laboratories based in Mobile, Alabama, will utilize SOPHiA DDM™ to develop a new cancer profiling solution. Synergy Oncology is a specialist in innovative platforms that improve patient care. The use of SOPHiA DDM™ for Hereditary Cancers Solution in Synergy Oncology's state-of-the-art laboratory tech...

Read More

Research

TURTLETREE AND SOLAR BIOTECH ENTER STRATEGIC PARTNERSHIP

TurtleTree | August 16, 2021

news image

Solar Biotech, led by industrial biotech expert Alex Berlin, has become a significant piece of the puzzle for sustainable food tech companies taking products to market. TurtleTree knew from the beginning that one of the biggest challenges for food tech companies was developing the technologies required to scale up bio-manufacturing processes. TurtleTree is a biotech company based in Singapore and the US. The company is focused on providing access to the best nutrients in milk usin...

Read More
news image

Cell and Gene Therapy

DELFI DIAGNOSTICS SELECTED AS THE LIQUID BIOPSY PARTNER FOR 4-IN-THE-LUNG-RUN: A LARGE-SCALE EUROPEAN LUNG CANCER SCREENING STUDY

Delfi Diagnostics | September 12, 2022

Delfi Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has been selected as the liquid lung cancer biopsy partner in Europe's multi-national, randomized, prospective lung cancer screening trial known as 4-IN-THE-LUNG-RUN, or 4ITLR. Through 4ITLR, European investigators are studying how often – every year, or every other year – individuals should get screened if their in...

Read More
news image

Industrial Impact

AMNIO TECHNOLOGY LAUNCHES TWO NEW DUAL-LAYER ALLOGRAFTS, FDA RECOGNIZES PRODUCTS AS MINIMALLY MANIPULATED, HOMOLOGOUS USE HCT/PS

Amnio Technology | February 15, 2022

Amnio Technology, a global leader in the development of and distribution of amniotic tissue allografts is announcing the launch of two new PalinGen® membrane products, PalinGen® Dual-Layer Membrane and Dual Layer PalinGen® X-Membrane. The new allografts, like the entire family of PalinGen® membrane products, are minimally manipulated, homologous use and chorion-free. The dual-layered nature of the allografts allow for unidirectional application with two outward facing epithelial ...

Read More
news image

MedTech, Industrial Impact

SYNERGY ONCOLOGY TO USE SOPHIA DDM FOR NEW CANCER PROFILING SOLUTION

SOPHiA GENETICS | March 01, 2023

On February 28, 2023, SOPHiA GENETICS, a leading cloud-native software solutions provider in the healthcare space, announced that Synergy Oncology, a part of Synergy Laboratories based in Mobile, Alabama, will utilize SOPHiA DDM™ to develop a new cancer profiling solution. Synergy Oncology is a specialist in innovative platforms that improve patient care. The use of SOPHiA DDM™ for Hereditary Cancers Solution in Synergy Oncology's state-of-the-art laboratory tech...

Read More
news image

Research

TURTLETREE AND SOLAR BIOTECH ENTER STRATEGIC PARTNERSHIP

TurtleTree | August 16, 2021

Solar Biotech, led by industrial biotech expert Alex Berlin, has become a significant piece of the puzzle for sustainable food tech companies taking products to market. TurtleTree knew from the beginning that one of the biggest challenges for food tech companies was developing the technologies required to scale up bio-manufacturing processes. TurtleTree is a biotech company based in Singapore and the US. The company is focused on providing access to the best nutrients in milk usin...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us